![Foto de JOSE JAVIER](/img/nophoto.png)
JOSE JAVIER
ARAIZ IRIBARREN
PROFESORADO TITULAR DE UNIVERSIDAD
Publicaciones (42) Publicaciones de JOSE JAVIER ARAIZ IRIBARREN
2023
-
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Ophthalmology, Vol. 130, Núm. 6, pp. 588-597
-
Absceso subretiniano por Nocardia en paciente inmunodeprimido: a propósito de un caso
Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 656-659
-
Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study
International Ophthalmology, Vol. 43, Núm. 12, pp. 4639-4649
2022
-
Evaluation of Macular Thickness Changes after Uncomplicated Phacoemulsification Surgery in Healthy Subjects and Diabetic Patients without Retinopathy by Spectral Domain OCT
Diagnostics, Vol. 12, Núm. 12
-
The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world
Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531
2021
-
Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons
Frontiers in Pharmacology, Vol. 12
-
The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival
Frontiers in Pharmacology, Vol. 12
2020
-
Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study
Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829
-
Comparative lipidomic analysis of mammalian retinal ganglion cells and Müller glia in situ and in vitro using High-Resolution Imaging Mass Spectrometry
Scientific Reports, Vol. 10, Núm. 1
-
Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
Lupus, Vol. 29, Núm. 7, pp. 671-675
-
Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients
PloS one, Vol. 15, Núm. 7, pp. e0236071
2018
-
Efficacy and safety of an aflibercept treat-and-extend regimen in treatment-naïve patients with macular oedema secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
Journal of Ophthalmology, Vol. 2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
-
The retina of osteopontin deficient mice in aging
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 213-221
2016
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome
Retina, Vol. 35, Núm. 12, pp. 2450-2456
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014